Complexion Clearing Salicylic Acid Acne Treatment Pads
Natural health product licensed in Canada
Oral dose analysis does not apply without an established exclusively oral route.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source |
|---|---|
| Acide 2-hydroxybenzoïque Source : Acide salicylique | 0.5 % |
Non-medicinal ingredients
Sorbate de potassium, Extrait de fruit de Citrus Limon (Citron), Extrait d'Acer saccharum (Érable à sucre), Benzoate de sodium, Lauryl glucoside, Phénoxyéthanol, Caprylyl glycol, Citrate de sodium, Eau, Extrait d'écorce/ de Feuilles/ de branches de Hamamelis Virginiana (hamamélis), Extrait de fruit de Vaccinium Myrtillus, Acide citrique, Niacinamide, Hydroxyde de sodium, Extrait de Saccharum officinarum (Cane à sucre), PPG-5-céteth-20, Formylprolinate tétraméthylhexadécénylcystéine de disodium, Extrait de fruit de Citrum Aurantium Dulcis (Oranger), EDTA de sodium, Lauryl glucose carboxylate de sodium, Jus de feuilles d'Aloe Barbadensis, Acide sorbique
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes et adolescents | minimum: 12 years | 1 wipe | minimum: 1 Tous les jours ; maximum: 3 Tous les jours |
Uses authorised in Canada
For the treatment/management of acne. Helps treat acne pimples (and allows skin to heal) Dries and helps clear up acne pimples (and allows skin to heal) Reduces the number and/or severity of acne pimples (and allow skin to heal) Penetrates pores to control/ reduce acne pimples Helps keep skin clear of new acne pimples Helps prevent new acne pimples from forming Acne treatment Helps prevent acne Helps prevent acne pimples Helps clear acne Acne treatment/medication Helps treat acne/pimples Reduces the number of pimples.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Effets indésirables connus
Stop use and consult health care practitioner professional if you develop severe irritation, burning or itching of the skin. Allergy alert get medical help right away if you develop hives, swelling of eyes and mouth, blistering, or difficulty breathing.
- Précautions et mises en garde
For external use only. Consult a health care practitioner before use if you have severe acne. When using this product skin irritation and dryness are more likely to occur when using another topical acne product at the same time. If irritation occurs, use only one product at a time. When using this product avoid contact with eyes. If contact occurs, rinse thoroughly with water. Stop use and ask a health care professional if improvement is not apparent within 6-8 weeks. Keep out of reach of children. If swallowed, call a poison control centre or get medical help right away.
Product record
- Licence holder
- Neora, LLC
- NPN or DIN-HM
- 80095745
- Status
- Active licence
- Licence date
- 25 November 2019
- Revision date
- Not provided
- Form
- Serviette, traité
- Route of administration
- Topique
- Application type
- Officinale
Source
Official Health Canada record, licence 80095745
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “Complexion Clearing Salicylic Acid Acne Treatment Pads (Neora, LLC): composition and ingredients”, https://compoatlas.com/en/supplements/canada/80095745-complexion-clearing-salicylic-acid-acne-treatment-pads, updated 25 November 2019.